BPC-157 and TB-500: A Combined Tissue-Repair Research Overview
By Peptura Research Team/7 May 2026/8 min read
Two Peptides, Read Together
BPC-157 and TB-500 sit at the centre of the preclinical tissue-repair literature. Both turn up constantly in repair-signalling research, yet they are mechanistically separate molecules with little in common chemically. UK researchers can source both BPC-157 5mg and TB-500 5mg from Peptura with full third-party HPLC documentation.
BPC-157 in Brief
BPC-157, or Body Protection Compound-157, is a synthetic 15-amino-acid pentadecapeptide reproduced from a protective protein found in human gastric juice. Its sequence runs Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. What sets it apart is its stability in acidic gastric conditions, a resilience that makes it a dependable subject across both in-vitro and in-vivo designs.
TB-500 in Brief
TB-500 is a synthetic fragment of Thymosin Beta-4 (Tβ4), a 43-amino-acid protein found in blood platelets, wound fluid, and effectively every nucleated mammalian cell. The fragment carries the active actin-binding domain behind cell motility, sequestering G-actin monomers and steering cytoskeletal dynamics.
How the Mechanisms Diverge
BPC-157 is thought to work mainly at the local injury site through angiogenic and nitric-oxide-pathway routes. Research has probed its interplay with VEGF expression, growth-factor signalling, and the nitric oxide system across models of tendon, ligament, and gastrointestinal mucosal repair.
TB-500 acts systemically, sequestering G-actin monomers, regulating cytoskeletal dynamics, and encouraging cell migration throughout the body. Its research record leans toward cardiac tissue repair after ischaemic events, dermal wound models, corneal epithelium, and hair-follicle biology.
Combined Research Protocols
The two are frequently studied together in preclinical repair research, and the rationale is complementarity: BPC-157's local angiogenic and nitric-oxide effects alongside TB-500's systemic actin regulation and cell migration. Groups investigating repair-signalling pathways often run both to look for synergy at the cellular level. Keep them in separate vials unless a protocol specifically calls for a combined solution, since mixing muddies concentration calculations.
Laboratory Handling
Both arrive as lyophilised powders. Store lyophilised vials at -20°C and reconstituted solution at 2-8°C, using within four weeks. Reconstitute with bacteriostatic water by running it slowly down the vial wall and swirling gently, never shake. Aliquot the reconstituted stock to spare it repeated freeze-thaw cycles.
Sourcing in the UK
Peptura supplies research-grade BPC-157 5mg at 98.6% purity (batch PEP-216) and TB-500 5mg at 99% purity (batch PEP-493), both third-party HPLC tested with full lab certificates published on the product pages. Same-day UK dispatch on orders before 2pm GMT. For in-vitro laboratory research only.
Related Products
Disclaimer: This article is for research and educational purposes only. All information provided is not intended as medical advice. Peptura products are not for human consumption and are sold strictly for laboratory research use only.